To include your compound in the COVID-19 Resource Center, submit it here.

Arcing toward AI

British partnership using AI for early drug discovery

LifeArc announced in January it is tapping into AI capabilities at the University of Cambridge’s Milner Therapeutics Institute through a partnership aimed at identifying and validating new targets for cancer immunotherapy and respiratory disease early in the drug discovery process.

Catherine

Read the full 405 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE